Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.45 |
| ▸ | CCR1 | P32246 | 2/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | CCR2 | P41597 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17047801 | 0.80 | RXFP1 (0.43) | RAB9AMAPTKDM4EMEN1KMT2A | |
| SCHEMBL2643493 | 0.74 | KDM4E (0.50) | MAPTKDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL18317055 | 0.73 | HSD11B1 (0.41) | RAB9AMAPTKDM4EMEN1KMT2A | |
| SCHEMBL18317056 | 0.73 | GSK3A (0.50) | SMN1; SMN2MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL21944956 | 0.70 | SMN1; SMN2 (0.60) | RAB9ASMN1; SMN2MAPTKDM4EMEN1 | |
| SCHEMBL28956510 | 0.69 | RAB9A (0.67) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL17047646 | 0.69 | FAAH (0.42) | MAPTMEN1KMT2AGAARXFP1 | |
| SCHEMBL10555654 | 0.68 | RAB9A (1.00) | RAB9ASMN1; SMN2MAPTKDM4EMEN1 | |
| SCHEMBL10554814 | 0.67 | RAB9A (0.53) | RAB9ASMN1; SMN2MAPTKDM4EMEN1 | |
| SCHEMBL17047759 | 0.67 | XPO1 (0.40) | MAPTMEN1KMT2ACCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160368900-A1 | PLANT GROWTH REGULATING COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2016-12-22 | — | — | US | claimed |
| EP-3110808-B1 | PLANT GROWTH REGULATING COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-08-29 | — | — | EP | disclosed |
| US-9751867-B2 | Plant growth regulating compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-05 | — | — | US | disclosed |
| US-20160368900-A1 | PLANT GROWTH REGULATING COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160368900-A1 | PLANT GROWTH REGULATING COMPOUNDS | GHDC, GAK, EIF4G2 | RAB9A 1688/4885SMN1; SMN2 4877/4885MAPT 4341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.